Search Results - "Tepper, Joel E."

Refine Results
  1. 1

    Nanotechnology in radiation oncology by Wang, Andrew Z, Tepper, Joel E

    Published in Journal of clinical oncology (10-09-2014)
    “…Nanotechnology, the manipulation of matter on atomic and molecular scales, is a relatively new branch of science. It has already made a significant impact on…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Radiation therapy‐associated toxicity: Etiology, management, and prevention by Wang, Kyle, Tepper, Joel E.

    Published in CA: a cancer journal for clinicians (01-09-2021)
    “…Radiation therapy (RT) is a curative treatment for many malignancies and provides effective palliation in patients with tumor‐related symptoms. However, the…”
    Get full text
    Journal Article
  5. 5

    Practice Patterns and Long-Term Survival for Early-Stage Rectal Cancer by STITZENBERG, Karyn B, SANOFF, Hanna K, PENN, Dolly C, MEYERS, Michael O, TEPPER, Joel E

    Published in Journal of clinical oncology (01-12-2013)
    “…Standard of care treatment for most stage I rectal cancers is total mesorectal excision (TME). Given the morbidity associated with TME, local excision (LE) for…”
    Get full text
    Journal Article
  6. 6

    Technology Evolution: Is It Survival of the Fittest? by ZIETMAN, Anthony, GOITEIN, Michael, TEPPER, Joel E

    Published in Journal of clinical oncology (20-09-2010)
    “…New technologies are constantly being developed and introduced into medical practice. Their potential or actual use raises questions of efficacy and cost. All…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Wound Complications in Preoperatively Irradiated Soft-Tissue Sarcomas of the Extremities by Rosenberg, Lewis A., MD, PhD, Esther, Robert J., MD, Erfanian, Kamil, MD, Green, Rebecca, MSW, Kim, Hong Jin, MD, Sweeting, Raeshell, MD, Tepper, Joel E., MD

    “…Purpose To determine whether the involvement of plastic surgery and the use of vascularized tissue flaps reduces the frequency of major wound complications…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Radiosensitization of Epidermal Growth Factor Receptor/HER2–Positive Pancreatic Cancer Is Mediated by Inhibition of Akt Independent of Ras Mutational Status by KIMPLE, Randall J, VASEVA, Angelina V, COX, Adrienne D, BAERMAN, Kathryn M, CALVO, Benjamin F, TEPPER, Joel E, SHIELDS, Janiel M, SARTOR, Carolyn I

    Published in Clinical cancer research (01-02-2010)
    “…Purpose: Epidermal growth factor receptor (EGFR) family members (e.g., EGFR, HER2, HER3, and HER4) are commonly overexpressed in pancreatic cancer. We…”
    Get full text
    Journal Article
  13. 13

    Impact of Number of Nodes Retrieved on Outcome in Patients With Rectal Cancer by TEPPER, Joel E, O'CONNELL, Michael J, NIEDZWIECKI, Donna, HOLLIS, Donna, COMPTON, Carolyn, BENSON, Al B, CUMMINGS, Bernard, GUNDERSON, Leonard, MACDONALD, John S, MAYER, Robert J

    Published in Journal of clinical oncology (01-01-2001)
    “…We postulated that the pathologic evaluation of the lymph nodes of surgical specimens from patients with rectal cancer can have a substantial impact on time to…”
    Get full text
    Journal Article
  14. 14

    Biomarkers for Response to Neoadjuvant Chemoradiation for Rectal Cancer by Kuremsky, Jeffrey G., B.A, Tepper, Joel E., M.D, McLeod, Howard L., Pharm.D

    “…Locally advanced rectal cancer (LARC) is currently treated with neoadjuvant chemoradiation. Although approximately 45% of patients respond to neoadjuvant…”
    Get full text
    Journal Article
  15. 15

    Intraoperative electron radiation therapy as an important treatment modality in retroperitoneal sarcoma by Sweeting, Raeshell S., MD, Deal, Allison M., MS, Llaguna, Omar H., MD, Bednarski, Brian K., MD, Meyers, Michael O., MD, Yeh, Jen Jen, MD, Calvo, Benjamin F., MD, Tepper, Joel E., MD, Kim, Hong Jin, MD

    Published in The Journal of surgical research (01-11-2013)
    “…Abstract Background Local recurrence (LR) rates in patients with retroperitoneal sarcoma (RPS) are high, ranging from 40% to 80%, with no definitive studies…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Abeloff's clinical oncology by Niederhuber, John E, Armitage, James O, Doroshow, James H, Kastan, Michael B, Tepper, Joel E

    Published 08-01-2019
    “…This reference synthesises modern oncology knowledge in one practical, clinically focused, easy-to-use volume. It incorporates basic science, pathology,…”
    Get full text
    eBook
  18. 18

    Impact of Surgical and Pathologic Variables in Rectal Cancer: A United States Community and Cooperative Group Report by STOCCHI, Luca, NELSON, Heidi, SARGENT, Daniel J, O'CONNELL, Michael J, TEPPER, Joel E, KROOK, James E, BEART, Robert JR

    Published in Journal of clinical oncology (15-09-2001)
    “…Substantial and successful effort has been focused on decreasing the risk of local failure after rectal cancer surgery through the use of adjuvant therapies…”
    Get full text
    Journal Article
  19. 19
  20. 20